Multiple biomarker models for improved risk estimation of specific cardiovascular diseases related to metabolic...

Metabolic syndrome (MetS) is the co-occurrence of several conditions that increase risk of chronic disease and mortality. Multivariate models for calculating risk of MetS-related diseases based on combinations of biomarkers are promising for future risk estimation if based on large population samples. Given biomarkers' nonspecificity and commonality in predicting diseases, we hypothesized that unique combinations of the same clinical diagnostic criteria can be used in different multivariate models to develop more accurate individual and cumulative risk estimates for specific MetS-related diseases.

We utilized adult biomarker and cardiovascular disease (CVD) data from the National Health and Nutrition Examination Survey as part of a cross-sectional analysis. Serum C-reactive protein (CRP), glycohemoglobin, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol, fasting glucose, and apolipoprotein-B were modeled. CVDs included congestive heart failure, coronary heart disease, angina, myocardial infarction, and stroke. Decile analysis for disease prevalence in each biomarker group and multivariate logistic regression for estimation of odds ratios were employed to measure the joint association between multiple biomarkers and CVD diagnoses.

Of the biomarkers considered, glycohemoglobin, triglycerides, and CRP were consistently associated with the CVD outcomes of interest in decile analysis and were selected for the final models. Associations were overestimated when using single-marker models in comparison with full models; individual odds ratios decreased an average of 16.4% from the single-biomarker models to the joint association models for CRP, 6.6% for triglycerides, and 1.4% for glycohemoglobin. However, joint associations were stronger than any single-marker estimate. Additionally, reduced models produced unique combinations of biomarkers for specific CVD outcomes.

The reduced joint association modeling results suggest that unique combinations of biomarkers with their related measure of association can be used to produce more accurate cumulative risk estimates for each CVD. Additionally, our results indicate that the use of multiple biomarkers in a single multivariate model may provide increased accuracy of individual biomarker association estimates by controlling for statistical artifacts and spurious relationships due to co-biomarker confounding.